Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

NCT06305390 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06305390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06305390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Recruiting
Start date
December 4, 2023
Completion date
April 30, 2027
Enrollment
167 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical suspicion of prostate cancer